Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 549.00p 15,720 06:30:28
Bid Price Offer Price High Price Low Price Open Price
538.00p 560.00p 549.00p 549.00p 549.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 61.4 13.5 16.4 33.6 360.98

Eco Animal Health (EAH) Latest News

More Eco Animal Health News
Eco Animal Health Takeover Rumours

Eco Animal Health (EAH) Share Charts

1 Year Eco Animal Health Chart

1 Year Eco Animal Health Chart

1 Month Eco Animal Health Chart

1 Month Eco Animal Health Chart

Intraday Eco Animal Health Chart

Intraday Eco Animal Health Chart

Eco Animal Health (EAH) Discussions and Chat

Eco Animal Health Forums and Chat

Date Time Title Posts
25/5/201811:47Eco Animal Health Group: Early dewormer gets OK909

Add a New Thread

Eco Animal Health (EAH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Eco Animal Health trades in real-time

Eco Animal Health (EAH) Top Chat Posts

Eco Animal Health Daily Update: Eco Animal Health Group is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker EAH. The last closing price for Eco Animal Health was 549p.
Eco Animal Health Group has a 4 week average price of 544p and a 12 week average price of 530p.
The 1 year high share price is 680p while the 1 year low share price is currently 515p.
There are currently 65,753,046 shares in issue and the average daily traded volume is 62,988 shares. The market capitalisation of Eco Animal Health Group is £360,984,222.54.
mad foetus: Yes, it is getting frustrating. Quality company but nobody like a share price that drifts down.
tanners: Panic Investor - IGR and EAH are very different businesses. EAH has as deep and wide a moat as you'll would take a competitor a long time to gain all the regulatory approvals, though I will confess I don't know whether others are attempting to develop rival products. The key is the fact that further authorisations are gained with comforting regularity; the difficult bit as I posted a few weeks back is trying to estimate what each might be worth in terms of revenue. To that end I'm compiling a spreadsheet of approvals, and attempting to link that via results to segmental revenue growth in different markets......I've gone back 5 years and whilst not entirely straightforward, I'm happy to share the results when I'm done; if anyone is interested and I think they are meaningful. In the meantime there will be periods when the share price will stagnate or even drift a bit, these movements do not concern me as long as the approvals keep coming and revenue keeps view is that we are in the infancy of a growth Company so until that story changes I'm staying invested, which hopefully will be for some years to come! PS Off topic - hadn't looked at IGR for some time but gotta say the current management are doing a fantastic real protection of product but impressive all the same, and I'm going to do some further research.
tanners: Indeed......very difficult to guestimate what each approval might add in terms of revenue/profit, but a 2% increase in the share price would appear modest!
nfs: A new investor from a few weeks ago. Disappointing that the share price didn't go up post results but it's been roaring up in the last 18 months, so I have to accept that I need to wait and watch the company performance improve each reporting period and trust the share price will follow
aimingupward2: Have just seen your post, Au, and would like to thank for it and the reassurance it gives. I came to the board thinking I might post a comment along the lines that the interims haven't done anything for the share price (yet anyway) and there you were having said just that! Never mind. The strong upward trend, which has been going for over 18 months, is clearly still intact.
audigger: Would be strange if we didn't have interims by end of next week at latest. As for my bet, it's a little complicated but I have set a stop loss at 491 which means if the buy price hits that level my bet automatically closes. So using my £20 a point example I would lose 528-491 x 20 = 740 quid. However this amount of loss isn't guaranteed under circumstances where the share price is very volatile either due to general market volatility or major bad news for the company. If there is a dramatic fall in share price in one day, say £1,then my loss would be 100x 20 = £2000. This is why you have to stump up extra cash to secure you're bet. They call this a slippage factor and it's always higher for AIM shares that aren't particularly liquid. The same bet on BP, Lloyds or Rolls Royce would be much cheaper. In terms of profit you have a choice. You can set a level at which your bet automatically closes and you earn a known amount of profit or you can keep the bet open up to the expiry date. In this situation I would never set a level at which I close the bet with a pre-determined profit because I have absolutely no idea how much upside there could be especially if the company is taken over by a big player. If....and it's a big if, they were taken out at £10 per share whilst my bet is live then the profit would be 1000-538x20 = £9240. My realistic expectation is to make about £2000 but I am risking losing a minimum of £740 which is unlikely but possible. I'd be very surprised if there was a dramatic fall in share price and I lost £1800....but it's a possibility. I also own shares which I will keep for at least 10 years and hopefully will collect nice dividends along the way. I just don't have enough free cash right now to give me the exposure I want hence the spread bet.
audigger: Now there's a question! Basically you bet an amount on every 1 pence (referred to as a 1 point) movement in the share price. You can bet on the price increasing (going long) or decreasing (going short). At the point at which you open the bet you incur a cost which is the spread in the share price. For EAH when I took out my bet this spread was 498 (sell price)-528 (buy price). Obviously I bet on an increase in share price so I "bought" at 528. This means I immediately incur a loss as the value of my bet is set at the sell price. Say I bet £20 per point on opening my bet the cost of the spread means I'm instantly £20 x 30 (the spread) down = £600. I need the sale price to increase above 528 to be in profit. Effectively a £20 bet gives you the same exposure as owning 2000 shares. To place the bet you need to stump up a deposit/margin which for a £20 bet is about £1800. This is considerably cheaper than what it would cost to buy 2000 shares at £5 (so-called leverage). The downside however, is that you can quite easily loose all your money if the price moves against you. You can manage this risk by setting a stop-loss; a price at which the bet is closed if it moves against you. My expectation is that by June 2017 the share price should be at least £1 higher than it is today (that's no more than a judgement call!) so if that happens with the £20 bet example, the profit is £2000. You can bet any amount from 50p to thousands of pounds. The higher the bet the higher your initial outlay. Its not for the faint-hearted and I would never bet with more than I could afford to loose because it can all disappear in an instant (unlike owning the shares where there is also the opportunity to hold out for a recovery.
aimingupward2: The D Telegraph today looks at 6 British companies that 'could emulate the huge share price gains made by the tonic water maker Fever Tree'. EAH is picked out as one of them!! A bit ott, I would have thought, but a nice show of confidence anyway.
smelleroo: hearing from my broker peel hunt have increased their target share price for eco
audigger: Article below is at this link: hxxp:// The stock of Eco Animal Health Group Plc (LON:EAH) hit a new 52-week high and has GBX 897.35 target or 133.00% above today’s GBX 385.13 share price. The 6 months bullish chart indicates low risk for the GBX 245.39 million company. The 1-year high was reported on May, 3 by If the GBX 897.35 price target is reached, the company will be worth GBX 326.37 million more. The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 1.75% or GBX 6.63 on May 3, hitting GBX 385.13. About 80,400 shares traded hands. Eco Animal Health Group Plc (LON:EAH) has risen 25.12% since October 1, 2015 and is uptrending. It has outperformed by 17.35% the S&P500. ECO Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The company has a market cap of 245.39 million GBP. The principal activity of the Company is the manufacture and supply of animal health products, which is conducted on global scale through a network, including both regional offices and overseas subsidiaries. It has a 50.65 P/E ratio. The Firm has investments in the intellectual property of Aivlosin, which its patented molecule. I think we'd be happy with 897!
Eco Animal Health share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180525 15:02:07